Hey, welcome to VoraPrep Audio. Glad you could tune in.
Imagine a classic scenario. It comes up on the Series 79 and in your first year on the desk. A private equity client calls your team. They’re looking at buying a company, and they want to know what it’s worth. Not just one number. They need a real, defensible valuation range. They want its intrinsic value. They want to know what similar public companies are trading for. And what other buyers have paid for similar businesses. Finally, they need to know what kind of return they could expect if they buy it using a lot of debt.
This is the core of investment banking valuation. On exam day, you need to know exactly which tools to pull out of the toolbox and why.
Think of valuing a company like figuring out the price of a house. You wouldn't just use one method. You’d look at the recent sales on the same street. That’s like our Precedent Transactions. You'd check the listing prices of similar houses for sale right now. That's our Trading Comps. You might also calculate the potential rental income it could generate. That’s a bit like a Discounted Cash Flow analysis. And a house-flipper might have their own number, based on what they can afford to pay to still make their target profit. That’s like an LBO analysis.
Each method gives you a different angle, a different data point. Your job is to bring them all together. The four big ones you need to know are DCF, Comparable Company Analysis, Precedent Transactions, and LBO. Analysis.
First up is the one that feels the most academic. The Discounted Cash Flow analysis, or DCF. This is an intrinsic valuation. That word is key. It means we're figuring out what the company is worth based purely on its own ability to generate cash in the future. We're ignoring what the noisy stock market is doing today.
Here's how it works. You project the company’s Free Cash Flows for the next five or ten years. That's the 'discrete forecast period'. Then, you estimate what it's worth for all the years after that, which we call the Terminal Value. You add all those future cash flows up. Then you have to pull them back to today's dollars. Why? Because a dollar tomorrow is worth less than a dollar today.
The rate we use to discount it is the Weighted Average Cost of Capital, or WACC. Now, the WACC isn't just a simple blend of debt and equity costs. It's a precise formula representing the company's blended cost of capital. You calculate it by taking the cost of equity and multiplying it by the percentage of equity in the capital structure. Then, you add the after-tax cost of debt, multiplied by the percentage of debt. We use the after-tax cost because interest payments are tax-deductible. This creates a tax shield that lowers the true cost of debt.
The big strength of a DCF is that it’s based on fundamentals. The downside? It's incredibly sensitive to your assumptions. A tiny change to your growth rate or your WACC can swing the valuation. A lot.
Okay, so that’s the intrinsic view. Now for the relative views. The first is Comparable Company Analysis, which you'll usually hear called Trading Comps. The idea here is simple: similar companies should be valued similarly by the market. So, you find a group of publicly traded companies that are in the same industry, about the same size, with similar growth prospects. This is your peer group. Then you look at their valuation multiples. A really common one is Enterprise Value to EBITDA. You calculate the average or median multiple for the peer group. Then you apply that multiple to your target company's EBITDA. Voila. You have a valuation. It’s great because it’s grounded in what the market thinks right now. But it has weaknesses. Finding truly comparable companies can be really hard. And sometimes, the market is just irrational.
The next method, Precedent Transactions, is also a relative valuation. It’s a close cousin to Trading Comps, but with a crucial difference. We're not looking at how similar companies trade on the stock market today. Instead, we look at what buyers have actually paid to acquire similar companies in the past. We’re looking at real M and A deals. The key thing here is that these multiples usually include a control premium. That’s the extra amount a buyer is willing to pay to get full control of a company. You don't get that with a regular stock price. This method is awesome because it reflects what people are really willing to pay in the M and A market. The catch is that there might not be many good, recent, comparable deals to look at. And market conditions from an old deal might be totally different from today.
That brings us to our last one: the Leveraged Buyout, or LBO analysis. This one is different. It’s not trying to find a general market value. It’s trying to find the value from the perspective of a financial sponsor, like a private equity firm. These firms buy companies using a ton of debt. The whole point of an LBO analysis is to find the maximum price they can pay for a target. They need to do this while still hitting their required Internal Rate of Return, or IRR. That target is usually high, say, 20 to 25 percent. It’s all about the company's ability to generate cash to pay down that debt over time. So, an LBO analysis often gives you a "floor valuation." It tells you the price a PE firm might be willing to pay, which can be a useful baseline. Its main weakness is that it's highly dependent on the debt markets and really only applies to this one type of buyer.
So, how do you put this all together for an exam question or for that client? It's a pretty logical flow.
First, you have to understand the situation. Why are we doing this valuation? M and A? An IPO.? What kind of company is it? Then, you select the right tools from your toolbox. For a stable, mature company, a DCF is probably a good idea. If it has a lot of public peers, Trading Comps are a must. If it’s an M and A deal, you absolutely need to look at Precedent Transactions.
Next is the grunt work: gathering all the data, building your models, and finding your comps. You have to make sure all the numbers are standardized. After you run the numbers for each method, you'll have a few different valuation outputs. They won't be the same. This is where the art comes in. You triangulate. You look at the different ranges and understand why they're different. Then you synthesize them into one final, defensible valuation range to present to your client.
Now, a couple of things to watch out for on exam day. First, know the difference between intrinsic and relative. A DCF is intrinsic. Comps and Precedents are relative. It's a simple concept, but they love to test it. Second, be careful with the WACC. Remember, you use it to discount Free Cash Flow, and that gets you to Enterprise Value. Third, don't forget the control premium. Precedent Transactions have it. Trading Comps usually don't. Fourth, make sure your multiples match your value. An Enterprise Value multiple, like EV to EBITDA, gives you Enterprise Value. But a Price-to-Earnings multiple, or P to E, gets you to Equity Value. Don't mix them up. And finally, remember what an LBO is for. It’s not a general valuation. It’s an analysis of what a PE firm can afford to pay.
Alright, let's try a quick scenario. A mature, privately held manufacturing company has really stable cash flows. But there are very few public companies like it, and they're looking for a buyer. Which method would give you the most reliable intrinsic value? And why would Trading Comps be tough to use here?
(pause)
Okay, for the most robust intrinsic valuation, you'd lean heavily on a Discounted Cash Flow analysis. The company's stable, predictable cash flows are perfect for a DCF model. And Trading Comps? That would be really challenging. The source of your data—the peer group—is tiny or non-existent. Without good public comps, your multiples would be unreliable.
Let's do one more. An analyst is running an LBO for a private equity client. The client wants a 25 percent IRR. What’s the main goal of that LBO analysis? And what financial metric is crucial for seeing if the company can handle all the debt?
(pause)
The primary focus is to find the maximum price the PE firm can pay and still hit that 25 percent IRR target. It's all about their return. And to see if the company can support the debt, you'd be looking very closely at its EBITDA and its Free Cash Flow. Those tell you if there's enough cash coming in the door to make those heavy interest and principal payments.
So, to recap the big four: DCF is intrinsic, based on a company's own future cash flows. Trading Comps are relative, based on public peers. Precedent Transactions are also relative, but based on past M and A deals, and they include a control premium. And LBO analysis is for a financial sponsor, focused on debt and a target IRR. You almost always use more than one to triangulate a final range.
VoraPrep is a full exam-prep app — lessons, practice questions, and an AI tutor in one place. Get started at Vora Prep dot com.